Alliance Pharma Targeting M&A To Grow OTC Portfolio
UK-based Alliance Pharma is currently looking at deals - large and small - to expand its consumer health portfolio in its existing markets, including the US and Europe.
You may also be interested in...
UK-based Alliance Pharma has strengthened its US offering by acquiring Biogix and its Amberen menopause supplement.
COVID-19 had a differing impact on Q2 consumer health sales for France's Boiron, the UK's Alliance Pharma and Sweden's Karo.
Round-up of the latest news across EMEA, including two deals for Bayer in Egypt and Saudi Arabia; Orkla's acquisition of NutraQ; and Uriach's deal for Sidroga.